Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) Equity Ratio (2018 - 2025)

Historic Equity Ratio for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to 0.57.

  • Health Catalyst's Equity Ratio rose 2946.38% to 0.57 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.57, marking a year-over-year increase of 2946.38%. This contributed to the annual value of 0.43 for FY2024, which is 1867.32% down from last year.
  • Health Catalyst's Equity Ratio amounted to 0.57 in Q3 2025, which was up 2946.38% from 0.56 recorded in Q2 2025.
  • Health Catalyst's 5-year Equity Ratio high stood at 0.65 for Q3 2021, and its period low was 0.42 during Q1 2025.
  • Over the past 5 years, Health Catalyst's median Equity Ratio value was 0.54 (recorded in 2023), while the average stood at 0.53.
  • Data for Health Catalyst's Equity Ratio shows a peak YoY increase of 3129.44% (in 2021) and a maximum YoY decrease of 2881.08% (in 2021) over the last 5 years.
  • Over the past 5 years, Health Catalyst's Equity Ratio (Quarter) stood at 0.63 in 2021, then fell by 9.96% to 0.56 in 2022, then fell by 7.46% to 0.52 in 2023, then dropped by 18.67% to 0.43 in 2024, then skyrocketed by 32.96% to 0.57 in 2025.
  • Its Equity Ratio stands at 0.57 for Q3 2025, versus 0.56 for Q2 2025 and 0.42 for Q1 2025.